Company Analysis 4DMedical Limited
1. Summary
Advantages
- The stock's return over the last year (591.18%) is higher than the sector average (-34.34%).
- Current debt level 4.56% is below 100% and has decreased over 5 years from 104.43%.
Disadvantages
- Price (2.35 $) is higher than fair price (1.44 $)
- Dividends (0%) are below the sector average (1.7%).
- The company's current efficiency (ROE=-46.87%) is lower than the sector average (ROE=14.51%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| 4DMedical Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -38.9% | 0.8% |
| 90 days | 69.1% | -35.9% | 4.9% |
| 1 year | 591.2% | -34.3% | 17.3% |
FDMDF vs Sector: 4DMedical Limited has outperformed the "Healthcare" sector by 625.52% over the past year.
FDMDF vs Market: 4DMedical Limited has outperformed the market by 573.92% over the past year.
Slightly volatile price: FDMDF is more volatile than the rest of the market on "OTC" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: FDMDF with weekly volatility of 11.37% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (2.35 $) is higher than the fair price (1.44 $).
Price is higher than fair: The current price (2.35 $) is 38.7% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-33.12) is lower than that of the sector as a whole (45.46).
P/E vs Market: The company's P/E (-33.12) is lower than that of the market as a whole (45.85).
5.3. P/BV
P/BV vs Sector: The company's P/BV (15.52) is higher than that of the sector as a whole (5.31).
P/BV vs Market: The company's P/BV (15.52) is higher than that of the market as a whole (4.38).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (171.52) is higher than that of the sector as a whole (4.3).
P/S vs Market: The company's P/S indicator (171.52) is higher than that of the market as a whole (12.4).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-3.18) is lower than that of the sector as a whole (17.43).
EV/Ebitda vs Market: The company's EV/Ebitda (-3.18) is lower than that of the market as a whole (24.93).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -1.12% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-1.12%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-61.97%).
6.4. ROE
ROE vs Sector: The company's ROE (-46.87%) is lower than that of the sector as a whole (14.51%).
ROE vs Market: The company's ROE (-46.87%) is lower than that of the market as a whole (51.21%).
6.6. ROA
ROA vs Sector: The company's ROA (-31.76%) is lower than that of the sector as a whole (7.45%).
ROA vs Market: The company's ROA (-31.76%) is lower than that of the market as a whole (36.06%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.14%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.78%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.7%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
